Every time the U.S. tries to rein in rising drug prices, we hear the same thing from pharma:
Stymie our profits, and you’ll get less innovation and fewer breakthrough treatments.
Does the evidence back up this constant refrain?

Check out more content on the episode page.

SIGN UP

Be the first to find out about upcoming episodes, live events, and more. We might even send you a #HealthPolicyValentine!

Hosts

Our co-hosts have decades of experience in journalism, medicine, and health economics. Together, they’ll bring you compelling stories and candid conversations.

Dan Gorenstein

Executive Producer & Co-Host

Sayeh Nikpay, PhD, MPH

Co-Host

Anupam Jena, MD, PhD

Co-Host

CONTACT US

Got a story idea? Want to advertise on our show? Email us at info@tradeoffs.org

Follow us @tradeoffspod and use #tradeoffs to discuss our episodes

DONATE

Reporting on complex health policy issues is no easy task. By supporting Tradeoffs, you help make our ambitious storytelling, relentless fact finding, and rigorous research possible.

Tradeoffs (EIN: 834075323) is a 501(c)(3) organization.

Supported by: